drugset / Trial / NCT06596876
A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is a multicenter, randomized, double-blind, double-dummy, active-controlled, Phase III clinical study. The aim of this trial is to evaluated the efficacy and assessed the safety of HRG2010 compared with a sustained-release cabridopa-levodopa formulation in Parkinson's Disease With Motor Fluctuations.
Timeline
- Start
- 2024-11-06
- Primary completion
- 2025-10-09
- Completion
- 2026-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbidopa/Levodopa | Unknown | — | Oral |
| Subject | HRG2010 | Unknown | — | Oral |